Cellular Biomedicine Group Inc. (NASDAQ: CBMG) today announced the Company's Board of Directors (the "Board") has approved a new ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE